<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05005676</url>
  </required_header>
  <id_info>
    <org_study_id>TOF 3D</org_study_id>
    <nct_id>NCT05005676</nct_id>
  </id_info>
  <brief_title>Evaluation of the New Acceleromyograph TOF 3D</brief_title>
  <official_title>Evaluation of the New Three-dimensional Acceleromyograph TOF 3D Compared With the Established TOF Watch SX.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kreiskrankenhaus Dormagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kreiskrankenhaus Dormagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The TOF 3D is a new acceleromyograph designed to assess the degree of a neuromuscular block&#xD;
      during anesthesia. The study compares the new three-dimensional technique with the&#xD;
      established TOF Watch SX.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The TOF 3D is a new acceleromyograph designed to assess the degree of a neuromuscular block&#xD;
      during anesthesia. The study compares the new three-dimensional technique with the&#xD;
      established TOF Watch SX. The time course of a neuromuscular block (onset, maximal block,&#xD;
      time to recovery) is assessed simultaneously with both devices in 50 patients undergoing&#xD;
      elective gynecologic surgery requiring neuromuscular block. The validity and reliability of&#xD;
      the new technique is evaluated with a Bland-Altman- analysis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 15, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>TOF-R 90%</measure>
    <time_frame>12 months</time_frame>
    <description>Difference of the 90% train-of-four (TOF) recovery time between both devices</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>repeatability (precision)</measure>
    <time_frame>12 months</time_frame>
    <description>Variance of 10 consecutive measurements around a linear regression line for each device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bias and limits of agreement (Bland-Altman analysis)</measure>
    <time_frame>12 months</time_frame>
    <description>Difference between both devices against the average of both measurements (bias +- 2SD)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Assessment of a New Acceleromyograph</condition>
  <condition>Neuromuscular Block</condition>
  <arm_group>
    <arm_group_label>adductor pollicis AP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Measurement site: M.adductor pollicis of both arms.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Corrugator supercilii CS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Measurement site: M. corrugator supercilii at both sides</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>acceleromyography</intervention_name>
    <description>Simultaneous measurement of the time course of a neuromuscular block with 2 acceleromyographs</description>
    <arm_group_label>Corrugator supercilii CS</arm_group_label>
    <arm_group_label>adductor pollicis AP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing elective gynecologic surgery requiring general anesthesia and&#xD;
             neuromuscular block&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  anticipated difficult airway&#xD;
&#xD;
          -  Risk of pulmonary aspiration&#xD;
&#xD;
          -  acute infection&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  renal or hepatic insufficiency&#xD;
&#xD;
          -  neuromuscular disease&#xD;
&#xD;
          -  chronic intake of drugs influencing neuromuscular block&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stefan Soltesz, Prof.</last_name>
    <phone>00492133664500</phone>
    <email>stefan.soltesz@kkh-ne.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>GÃ¼nter K Noe, MD</last_name>
    <phone>00492133664600</phone>
    <email>karl-guenter.noe@kkh-ne.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>KKH Dormagen</name>
      <address>
        <city>Dormagen</city>
        <zip>D-41540</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soltesz, MD</last_name>
      <phone>0049 2133 66 4500</phone>
      <email>stefan.soltesz@kkh-ne.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Soltesz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 2, 2021</study_first_submitted>
  <study_first_submitted_qc>August 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 13, 2021</study_first_posted>
  <last_update_submitted>August 6, 2021</last_update_submitted>
  <last_update_submitted_qc>August 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kreiskrankenhaus Dormagen</investigator_affiliation>
    <investigator_full_name>Stefan Soltesz</investigator_full_name>
    <investigator_title>Prof. Dr. Stefan Soltesz</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

